Jacobs Levy Equity Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Jacobs Levy Equity Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-42,942	Closed	-$1.25M	–	1099
2021 Q4	$1.25M	Buy	+42,942	New	+$1.23M	0.01%	706
2018 Q3	–	Sell	-34,493	Closed	-$135K	–	1091
2018 Q2	$135K	Sell	34,493 -52,925	-61%	-$184K	﹤0.01%	983
2018 Q1	$255K	Buy	+87,418	New	+$270K	﹤0.01%	889
2017 Q4	–	Sell	-52,189	Closed	-$164K	–	1081
2017 Q3	$164K	Sell	52,189 -30,225	-37%	-$114K	﹤0.01%	888
2017 Q2	$351K	Sell	82,414 -2,329	-3%	-$9.53K	0.01%	748
2017 Q1	$388K	Buy	84,743 +7,200	+9%	+$24.1K	0.01%	689
2016 Q4	$167K	Sell	77,543 -26,343	-25%	-$61.6K	﹤0.01%	849
2016 Q3	$313K	Sell	103,886 -17,000	-14%	-$45.7K	0.01%	804
2016 Q2	$308K	Sell	120,886 -23,314	-16%	-$65K	0.01%	874
2016 Q1	$424K	Buy	144,200 +91,510	+174%	+$490K	0.01%	770
2015 Q4	$432K	Sell	52,690 -6,381	-11%	-$51.5K	0.01%	583
2015 Q3	$422K	Buy	+59,071	New	+$493K	0.01%	601
2013 Q3	–	Sell	-37,722	Closed	-$341K	–	1033
2013 Q2	$341K	Buy	+37,722	New	+$395K	0.01%	795

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Jacobs Levy Equity Management's CDMO Position: Q1 2022 in Review

Jacobs Levy Equity Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 42,942 shares — an estimated $1.25M sold.

Jacobs Levy Equity Management first reported a position in CDMO in Q2 2013 and held it in 13 quarters. The position peaked at $1.25M in Q4 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

Jacobs Levy Equity Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Jacobs Levy Equity Management sold 42,942 Avid Bioservices, Inc. Common Stock shares in Q1 2022, an estimated $1.25M.
Jacobs Levy Equity Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
Jacobs Levy Equity Management's Avid Bioservices, Inc. Common Stock position peaked at $1.25M in Q4 2021.
193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2022, filed 16 May 2022.